1187209-15-9Relevant articles and documents
Design and synthesis of orally bioavailable serum and glucocorticoid-regulated kinase 1 (SGK1) inhibitors
Hammond, Marlys,Washburn, David G.,Hoang, Tram H.,Manns, Sharada,Frazee, James S.,Nakamura, Hiroko,Patterson, Jaclyn R.,Trizna, Walter,Wu, Charlene,Azzarano, Leonard M.,Nagilla, Rakesh,Nord, Melanie,Trejo, Rebecca,Head, Martha S.,Zhao, Baoguang,Smallwood, Angela M.,Hightower, Kendra,Laping, Nicholas J.,Schnackenberg, Christine G.,Thompson, Scott K.
experimental part, p. 4441 - 4445 (2010/04/05)
The lead serum and glucocorticoid-related kinase 1 (SGK1) inhibitors 4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid (1) and {4-[5-(2-naphthalenyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]phenyl}acetic acid (2) suffer from low DNAUC values in rat, due in par